Latest

19:31
【CAPINFO (01075.HK): Expects Interim Results to Swing to Loss of Approximately RMB 30-50 Million】NewTimeSpace News: On 12 August 2026, CAPINFO (01075.HK) issued a profit warning, expecting an interim loss attributable to equity shareholders of approximately RMB 30-50 million, swinging from a profit of RMB 9.54 million in the same period of 2025, mainly due to higher fulfillment costs, increased R&D investment and the one-off impact of a RMB 52.79 million liquidation gain recognized last year.
Tag： CAPINFO01075.HKProfit Warning
19:28
【CH TIANBAO GP (01427.HK): Expects Interim Net Loss to Widen to RMB 60-70 Million on Reduced Revenue】NewTimeSpace News: On 12 August 2026, CH TIANBAO GP (01427.HK) issued a profit warning, expecting its interim net loss to widen to RMB 60.0-70.0 million from RMB 37.3 million in the same period of 2025, mainly due to reduced revenue from fewer construction contracts following proactive control of undertaking scale and lower average selling prices of buildings.
Tag： CH TIANBAO GP01427.HKProfit Warning
19:19
【MULTIFIELD INTL (00898.HK): Expects Interim Profit to Fall to Approximately HK$ 100-120 Million on Lower Fair Value Gains on Financial Assets】NewTimeSpace News: On 12 August 2026, MULTIFIELD INTL (00898.HK) issued a profit warning. Consolidated profit attributable to shareholders for the interim period is expected to range from approximately HK$100 million to HK$120 million (versus around HK$238 million in the corresponding period of 2025). The decline is mainly driven by a drop in net fair value gains on financial assets at fair value through profit or loss from roughly HK$208 million to about HK$46 million, representing a non-cash movement.
Tag： MULTIFIELD INTL00898.HKProfit Warning
19:12
【HENGRUI PHARMA (01276.HK): HRS-4729 Injection Approved for Phase II Clinical Trial in Type 2 Diabetes】NewTimeSpace News: On 12 August 2026, HENGRUI PHARMA (01276.HK) disclosed that HRS-4729 Injection, an in-house developed GLP-1R/GIPR/GCGR tri-agonist polypeptide, received NMPA approval for a Phase II clinical trial in adult type 2 diabetes patients, with a Phase II trial for weight loss also being advanced, and cumulative R&D investment of approximately RMB 81.6 million.
Tag： HENGRUI PHARMA01276.HKR&D Progress
19:07
【CHUANGLIAN HOLD (02371.HK): Zhang Jie Resigns as Executive Director, Gao Rui Appointed to Replace Him, Effective 12 August 2026】NewTimeSpace News: On 12 August 2026, CHUANGLIAN HOLD (02371.HK) announced that Mr. Zhang Jie resigned as executive director effective 12 August 2026 and will remain a senior management member, and Ms. Gao Rui was appointed as executive director on the same date with a fixed one-year term and a monthly salary of RMB 30,000.
Tag： CHUANGLIAN HOLD02371.HKBoard Change
19:00
【DREAM INT'L (01126.HK): Expects Interim Net Profit to Decrease by 25%-35% on Higher Labor and Raw Material Costs】NewTimeSpace News: On 12 August 2026, DREAM INT'L (01126.HK) issued a profit warning, expecting its net profit for the six months ended 30 June 2026 to decrease by approximately 25% to 35% compared with the same period in 2025, mainly due to increased labor costs and higher raw material prices.
Tag： DREAM INTL01126.HKProfit Warning
18:56
【HERBS GROUP (02593.HK): Expects Interim Net Loss to Narrow by 40%-53% on Lower Advertising and Promotion Expenses】NewTimeSpace News: On 12 August 2026, Herb Standard Group (02593.HK) released a profit forecast. The interim net loss is expected to narrow to approximately HK$3.5 million to HK$4.5 million (compared with around HK$7.5 million in the same period of 2025), representing a reduction of roughly 40% to 53%. The improvement is mainly attributable to lower advertising and promotion expenses, which is partially offset by declines in revenue and gross profit resulting from weaker sales in the retail business.
Tag： HERBS GROUP02593.HKNet Loss Narrow
18:48
【TH MEDICAL-B (02697.HK): Wins Bidding for Yunnan Agricultural University Research Equipment Project, Deal Value RMB 2.8 Million】NewTimeSpace News: On 12 August 2026, TH MEDICAL-B (02697.HK) announced that it was confirmed as the winning supplier for a research equipment procurement project of Yunnan Agricultural University (Project No.: YNGH[2026]-0626), covering one set of multi-organ multi-sensor normothermic perfusion system with built-in ventilator, with a total transaction amount of RMB 2.8 million.
Tag： TH MEDICAL-B02697.HKBid Award
18:43
【ACOTEC-B (06669.HK): Expects Interim Results to Swing to Net Loss of up to RMB 80.9 Million on Termination of U.S. Clinical Project】NewTimeSpace News: On 12 August 2026, ACOTEC-B (06669.HK) issued a profit warning, expecting a net loss of not more than RMB 80.9 million for the six months ended 30 June 2026, versus a net profit of approximately RMB 88.6 million in the same period of 2025, mainly due to the termination of the U.S. clinical project for the AcoArt Litos paclitaxel-coated PTA balloon catheter, which triggered one-off impairment and expense provisions totaling approximately RMB 150.8 million.
Tag： ACOTEC-B06669.HKProfit Warning
18:39
【ASIASEC PPT (00271.HK): Expects Interim Net Loss to Widen to Approximately HK$ 110-120 Million on Lower Investment Property Fair Value】NewTimeSpace News: On 12 August 2026, Asia Properties & Finance (00271.HK) issued a profit warning. The Group expects the net loss for the six-month period ending 30 June 2026 to range from approximately HK$110 million to HK$120 million, widening from around HK$63 million in the corresponding period of 2025, mainly due to a larger fair value reduction of investment properties.
Tag： ASIASEC PPT00271.HKProfit Warning
18:30
【NEW SILKROAD (00472.HK): Expects Interim Net Loss to Narrow to Approximately HK 13.9 M i l l i o n t o H K 13.9MilliontoHK 17.0 Million, Mainly on Reduced Goodwill Impairment】NewTimeSpace News: On 12 August 2026, New Silk Road Holdings Group (00472.HK) released a profit forecast. The Group expects its net loss for the six-month period ending 30 June 2026 to narrow to approximately HK$13.9 million to HK$17.0 million, compared with around HK$41.7 million recorded in the same period of 2025, mainly due to lower impairment loss on goodwill.
Tag： NEW SILKROAD00472.HKNet Loss Reduction
18:23
【BQD (03866.HK): Regulatory Approval for Zhang Shixing's Independent Non-Executive Director Qualification, Effective 10 August 2026】NewTimeSpace News: On 12 August 2026, BQD (03866.HK) announced that the Qingdao Regulatory Bureau of the National Financial Regulatory Administration approved Mr. Zhang Shixing's qualification as an independent non-executive director of the Bank (Qing Jin Fu [2026] No. 158); he assumed office from 10 August 2026, while Mr. Fan Xuejun ceased to hold the relevant positions.
Tag： BQD03866.HKBoard Change
18:17
【OSL GROUP (00863.HK): Wong Koon Man Appointed as Executive Director, Effective 12 August 2026】NewTimeSpace News: On 12 August 2026, OSL GROUP (00863.HK) announced the appointment of Mr. Wong Koon Man as executive director with effect from 12 August 2026.
Tag： OSL Group Limited00863.HKBoard Change
18:01
【POU SHENG INT'L(03813.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 243.65 million, YoY increase of 29.87%】NewTimeSpace News: August 12, 2026, POU SHENG INT'L(03813.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 8.96 billion, decreased by 2.13% YoY.
Tag： POU SHENG INTL03813.HKprofit
17:59
【CKI HOLDINGS(01038.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 21.25 billion, YoY increase of 388.78%】NewTimeSpace News: August 12, 2026, CKI HOLDINGS(01038.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 2.07 billion, decreased by 6.16% YoY.
Tag： CKI HOLDINGS01038.HKprofit growth
17:58
【QIANHAI HEALTH(00911.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 2.84 million, YoY decrease of 40.43%】NewTimeSpace News: August 12, 2026, QIANHAI HEALTH(00911.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 116.76 million, decreased by 65.74% YoY
Tag： QIANHAI HEALTH00911.HKProfit declined
17:54
【HK Stock Connect Daily Report: Southbound Capital Posts Net Selling of HKD 2.906 Billion, Property and Memory Chip Concepts Rise Against the Trend - 20260812】On 12 August, Hong Kong's three major indices weakened across the board, with the Hang Seng Index down 0.83% at 25,440.17 points, the Hang Seng TECH Index down 0.99%, and turnover of HKD 216.779 billion. Property stocks strengthened, with CHINA JINMAO up 13.92% and YUEXIU PROPERTY up 9.99%, as Beijing's new property policies were implemented. Memory chip and optical communication concepts were active, with MONTAGE TECH up 7.60% and KB LAMINATES up 10.70%. Most tech stocks corrected, with TENCENT MUSIC-SW down 12.55%. Southbound capital recorded net selling of HKD 2.906 billion. MINIMAX-W surged 8.96% against the trend and HUA HONG GRACE rose 7.13%. GALAXY ENT's interim dividend increased nearly 30%, and NSING TECH raised prices of some chips by 10% to 20%.
Tag： HK Stock Connect Daily ReportREALORD TECHTencentE Fund CSI HK Equities Information Technology Integration ETFFullgoal CSI HK Equities Internet ETF
17:35
【IMPACT THERAP-B (07630.HK): Nominates IMP2794 as preclinical candidate compound, first KAT6A-specific PROTAC from self-owned targeted protein degradation platform】NewTimeSpace News: On 12 August 2026, IMPACT THERAP-B (07630.HK) announced the nomination of IMP2794 as a preclinical candidate compound, the first KAT6A-specific PROTAC degrader discovered through its self-owned targeted protein degradation platform, with over 1,000-fold selectivity over KAT6B, excellent in vivo anti-tumour efficacy in breast cancer CDX models and high oral bioavailability.
Tag： IMPACT THERAP-B07630.HKR&D Progress
17:29
【RENCO HOLDINGS (02323.HK): HKEX announces cancellation of listing effective 17 August 2026; shares suspended since January 2025】NewTimeSpace News: On 12 August 2026, the Stock Exchange of Hong Kong Limited announced that the listing status of RENCO HOLDINGS (02323.HK) will be cancelled under Rule 6.01A(1) of the Listing Rules with effect from 9:00 a.m. on 17 August 2026. Shares have been suspended since 20 January 2025, and the Company failed to resume trading by the 19 July 2026 deadline; the Listing Committee decided to delist the Company on 31 July 2026.
Tag： RENCO HOLDINGS02323.HKDelisting
17:22
【SIRNAOMICS-B (02257.HK): Completes subscription of 2,435,600 new shares, net proceeds of approximately HKD 11.3 million for working capital】NewTimeSpace News: On 12 August 2026, SIRNAOMICS-B (02257.HK) announced the completion of a subscription under general mandate, with 2,435,600 new shares allotted and issued at HKD 4.69 per share, representing approximately 2.17% of the issued shares immediately after completion. Net proceeds of approximately HKD 11.3 million will be used as general working capital.
Tag： SIRNAOMICS-B02257.HKH-share placement
Previous1..8990 919293..488     488 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments